Dow Jones

39 512,84

0,32%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Avalon Pharmaceuticals (MM) (AVRX)
Avalon Pharmaceuticals (MM) (AVRX) Actualités

AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:AVRX

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
13/05/2009	21h39	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
06/05/2009	22h48	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
06/05/2009	22h46	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
28/04/2009	22h49	Business Wire	Avalon Pharmaceuticals Announces Special Meeting Date	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
07/04/2009	21h00	Business Wire	Avalon Pharmaceuticals Receives Audit Opinion Containing Going Concern Statement	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
17/03/2009	20h00	Business Wire	Avalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq Delisting	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
10/03/2009	21h07	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
11/02/2009	22h11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
10/02/2009	23h04	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
22/12/2008	22h23	Business Wire	Avalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency Notice	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
25/11/2008	20h18	Business Wire	Avalon Pharmaceuticals Receives NASDAQ Deficiency Notice	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
07/11/2008	22h04	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
05/11/2008	22h29	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
28/10/2008	13h26	Business Wire	Clinical Data, Inc. to Acquire Avalon Pharmaceuticals	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
29/09/2008	21h16	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
26/09/2008	22h16	Business Wire	Avalon Pharmaceuticals Receives Nasdaq Deficiency Notice	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
26/08/2008	17h02	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
14/08/2008	17h53	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Quarterly Report (10-Q)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
13/08/2008	16h00	Business Wire	Avalon Pharmaceuticals Reports Second Quarter 2008 Results	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
05/08/2008	15h00	Business Wire	Avalon Pharmaceuticals Sets Second Quarter 2008 Conference Call Date	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
24/07/2008	18h07	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Amended Current report filing (8-K/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
18/07/2008	20h23	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
26/06/2008	14h00	Business Wire	Avalon Pharmaceuticals Nominates Lead Clinical Development Candidate in its Beta-catenin Pathway Inhibitor Program	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
07/05/2008	22h20	Business Wire	Avalon Pharmaceuticals Reports First Quarter 2008 Results	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
30/04/2008	14h00	Business Wire	Avalon Pharmaceuticals to Release First Quarter 2008 Results	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
29/04/2008	15h54	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
14/04/2008	17h00	Business Wire	Avalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein Func	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
31/03/2008	20h34	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Annual Report (10-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
19/03/2008	21h15	Business Wire	Avalon Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
17/03/2008	20h57	Edgar (US Regulatory)	Avalon Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)